About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Tg(CLEC4C-HBEGF)956Cln
transgene insertion 956, Marco Colonna
MGI:4847575
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cx1
Siglechtm1.1Cln/Siglech+
Tg(CLEC4C-HBEGF)956Cln/0
involves: C57BL/6 MGI:5511133
tg2
Tg(CLEC4C-HBEGF)956Cln/0 C57BL/6-Tg(CLEC4C-HBEGF)956Cln MGI:5511130


Genotype
MGI:5511133
cx1
Allelic
Composition
Siglechtm1.1Cln/Siglech+
Tg(CLEC4C-HBEGF)956Cln/0
Genetic
Background
involves: C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Siglechtm1.1Cln mutation (0 available); any Siglech mutation (24 available)
Tg(CLEC4C-HBEGF)956Cln mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
• diptheria toxin administration induces selective depletion of plasmacytoid dendritic cells (pDC), but does not reduce numbers of classical DC

immune system
• diptheria toxin administration induces selective depletion of plasmacytoid dendritic cells (pDC), but does not reduce numbers of classical DC




Genotype
MGI:5511130
tg2
Allelic
Composition
Tg(CLEC4C-HBEGF)956Cln/0
Genetic
Background
C57BL/6-Tg(CLEC4C-HBEGF)956Cln
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(CLEC4C-HBEGF)956Cln mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• diptheria toxin (DT) administration induced depletion of plasmacytoid dendritic cells (pDC)
• depletion efficiency in blood, spleen, liver and lymph nodes is approximately 90% 24-48 hrs after DT treatment
• decreased frequencies and numbers of antigen-specific CD8+ T cells in DT-treated mice infected with recombinant VSV expressing ovalbumin (VSV-OVA)
• spleens from VSV-OVA infected DT-treated mice are smaller and have fewer cells than controls
• spleens from VSV-OVA infected DT-treated mice are smaller and have fewer cells than controls
• 2.5 fold increase in number of IFNg-producing NK cells in DT-treated (pDC-depleted) mice as compared to untreated control
• increase in frequency of NK1.1+ and Ly49H+ NK cells in DT-treated (pDC-depleted) mice during later phase of murine cytomegalovirus (MCMV) infection as compared to untreated control
• Ly49H+ NK cells from DT-treated (pDC-depleted) mice are less efficient at killing target cells
• less specific lysis is observed in antigen-specific CD8+ T cells found in VSV-OVA infected DT-treated mice
• increased frequencies of IFNg-producing NKT cells found in spleens and livers of DT-treated (pDC-depleted) mice
• reduction in serum CCL4 observed in VSV-OVA infected DT-treated mice 24 hours post infection (p.i.)
• DT-treated (pDC-depleted) mice exhibit decreased serum IFNa secretion 36 hours post MCMV infection although no differences are observed at 48 hours p.i.
• DT-treated (pDC-depleted) mice exhibit decreased serum IFNa secretion 6 hours post infection with recombinant VSV expressing ovalbumin (VSV-OVA) but not at 12 or 24 hours p.i.
• DT-treated (pDC-depleted) mice exhibit a 3-4x increase in serum IFNg secretion as compared to untreated controls 48 hours after MCMV at 104 pfu, but not at 105 pfu
• increase in IL12 producing CD11chi cells in DT-treated mice as compared to control
• increase in serum IL12 in DT-treated mice
• intraperitoneal infection with murine cytomegalovirus (MCMV) in DT-treated (pDC-depleted) mice results in significantly higher viral titers in spleen and liver 3 days post infection (3 p.i.) as compared to untreated controls
• salivary glands from MCMV infected DT-treated mice at 8 p.i. have elevated viral loads at 104 pfu, but not at 105 pfu as compared to untreated controls
• infection with recombinant VSV results in higher viral titers in spleen at 6 hours p.i. as compared to untreated controls, but VSV is undetectable in periphery after 24 hours

hematopoietic system
• diptheria toxin (DT) administration induced depletion of plasmacytoid dendritic cells (pDC)
• depletion efficiency in blood, spleen, liver and lymph nodes is approximately 90% 24-48 hrs after DT treatment
• decreased frequencies and numbers of antigen-specific CD8+ T cells in DT-treated mice infected with recombinant VSV expressing ovalbumin (VSV-OVA)
• spleens from VSV-OVA infected DT-treated mice are smaller and have fewer cells than controls
• spleens from VSV-OVA infected DT-treated mice are smaller and have fewer cells than controls
• 2.5 fold increase in number of IFNg-producing NK cells in DT-treated (pDC-depleted) mice as compared to untreated control
• increase in frequency of NK1.1+ and Ly49H+ NK cells in DT-treated (pDC-depleted) mice during later phase of murine cytomegalovirus (MCMV) infection as compared to untreated control
• Ly49H+ NK cells from DT-treated (pDC-depleted) mice are less efficient at killing target cells
• less specific lysis is observed in antigen-specific CD8+ T cells found in VSV-OVA infected DT-treated mice
• increased frequencies of IFNg-producing NKT cells found in spleens and livers of DT-treated (pDC-depleted) mice





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/23/2024
MGI 6.23
The Jackson Laboratory